These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

654 related items for PubMed ID: 21874252

  • 1. Highly sensitive lens culinaris agglutinin-reactive α-fetoprotein is useful for early detection of hepatocellular carcinoma in patients with chronic liver disease.
    Oda K, Ido A, Tamai T, Matsushita M, Kumagai K, Mawatari S, Saishoji A, Kure T, Ohno K, Toyokura E, Imanaka D, Moriuchi A, Uto H, Oketani M, Hashiguchi T, Tsubouchi H.
    Oncol Rep; 2011 Nov; 26(5):1227-33. PubMed ID: 21874252
    [Abstract] [Full Text] [Related]

  • 2. Clinical utility of highly sensitive Lens culinaris agglutinin-reactive alpha-fetoprotein in hepatocellular carcinoma patients with alpha-fetoprotein <20 ng/mL.
    Toyoda H, Kumada T, Tada T, Kaneoka Y, Maeda A, Kanke F, Satomura S.
    Cancer Sci; 2011 May; 102(5):1025-31. PubMed ID: 21244578
    [Abstract] [Full Text] [Related]

  • 3. Highly sensitive Lens culinaris agglutinin-reactive α-fetoprotein: a new tool for the management of hepatocellular carcinoma.
    Toyoda H, Kumada T, Tada T.
    Oncology; 2011 May; 81 Suppl 1():61-5. PubMed ID: 22212938
    [Abstract] [Full Text] [Related]

  • 4. Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma.
    Durazo FA, Blatt LM, Corey WG, Lin JH, Han S, Saab S, Busuttil RW, Tong MJ.
    J Gastroenterol Hepatol; 2008 Oct; 23(10):1541-8. PubMed ID: 18422961
    [Abstract] [Full Text] [Related]

  • 5. Utility of Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein and des-gamma-carboxy prothrombin, alone or in combination, as biomarkers for hepatocellular carcinoma.
    Sterling RK, Jeffers L, Gordon F, Venook AP, Reddy KR, Satomura S, Kanke F, Schwartz ME, Sherman M.
    Clin Gastroenterol Hepatol; 2009 Jan; 7(1):104-13. PubMed ID: 18849011
    [Abstract] [Full Text] [Related]

  • 6. Sequential fluctuation pattern of serum des-gamma-carboxy prothrombin levels detected by high-sensitive electrochemiluminescence system as an early predictive marker for hepatocellular carcinoma in patients with cirrhosis.
    Shimizu A, Shiraki K, Ito T, Sugimoto K, Sakai T, Ohmori S, Murata K, Takase K, Tameda Y, Nakano T.
    Int J Mol Med; 2002 Mar; 9(3):245-50. PubMed ID: 11836630
    [Abstract] [Full Text] [Related]

  • 7. Clinical utility of AFP-L3% measurement in North American patients with HCV-related cirrhosis.
    Sterling RK, Jeffers L, Gordon F, Sherman M, Venook AP, Reddy KR, Satomura S, Schwartz ME.
    Am J Gastroenterol; 2007 Oct; 102(10):2196-205. PubMed ID: 17617202
    [Abstract] [Full Text] [Related]

  • 8. Clinical utility of lens culinaris agglutinin-reactive alpha-fetoprotein in the diagnosis of hepatocellular carcinoma: evaluation in a Thai referral population.
    Tanwandee T, Setthasin S, Charatcharoenwitthaya P, Chainuvati S, Leelakusolvong S, Pausawasdi N, Srikureja W, Pongprasobchai S, Manatsathit S, Kachintorn U, Ekpo P, Senawong S.
    J Med Assoc Thai; 2009 Mar; 92 Suppl 2():S49-56. PubMed ID: 19562986
    [Abstract] [Full Text] [Related]

  • 9. [The studies on early warning of Lens culinaris-reactive alpha-Fetoprotein (AFP-L3) detecting in primary hepatocellular carcinoma].
    Li YL, Ma HB, Guo JX, Shi JB, Xu J, Liu AX, Yang LH, Li BA, Mao YL.
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Oct; 22(5):336-8. PubMed ID: 19469167
    [Abstract] [Full Text] [Related]

  • 10. [Detection of alpha-fetoprotein-L3 using agglutinin-coupled spin column to be used in diagnosis of hepatocellular carcinoma].
    Sun GZ, Zhao XY, Li JH, Zhao GQ, Wang SX, Kong SL.
    Zhonghua Yi Xue Za Zhi; 2008 Jul 22; 88(28):1986-8. PubMed ID: 19062741
    [Abstract] [Full Text] [Related]

  • 11. Relationship between Lens culinaris agglutinin-reactive alpha-fetoprotein and pathologic features of hepatocellular carcinoma.
    Tada T, Kumada T, Toyoda H, Kiriyama S, Sone Y, Tanikawa M, Hisanaga Y, Kitabatake S, Kuzuya T, Nonogaki K, Shimizu J, Yamaguchi A, Isogai M, Kaneoka Y, Washizu J, Satomura S.
    Liver Int; 2005 Aug 22; 25(4):848-53. PubMed ID: 15998436
    [Abstract] [Full Text] [Related]

  • 12. Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein as a marker of prognosis and a monitor of recurrence of hepatocellular carcinoma after curative liver resection.
    Zhang XF, Lai EC, Kang XY, Qian HH, Zhou YM, Shi LH, Shen F, Yang YF, Zhang Y, Lau WY, Wu MC, Yin ZF.
    Ann Surg Oncol; 2011 Aug 22; 18(8):2218-23. PubMed ID: 21336512
    [Abstract] [Full Text] [Related]

  • 13. Alpha-fetoprotein reaction to Pisum sativum agglutinin in differentiation of benign liver diseases from hepatocellular carcinoma.
    Yin ZF, Tu ZX, Cui ZF, Wu MC.
    Chin Med J (Engl); 1993 Aug 22; 106(8):615-8. PubMed ID: 7693403
    [Abstract] [Full Text] [Related]

  • 14. Clinical significance of lens culinaris agglutinin-reactive fraction of serum alpha-fetoprotein in patients with hepatocellular carcinoma.
    Yoshida S, Kurokohchi K, Arima K, Masaki T, Hosomi N, Funaki T, Murota M, Kita Y, Watanabe S, Kuriyama S.
    Int J Oncol; 2002 Feb 22; 20(2):305-9. PubMed ID: 11788893
    [Abstract] [Full Text] [Related]

  • 15. Prognostic importance of fucosylated alpha-fetoprotein in hepatocellular carcinoma patients with low alpha-fetoprotein.
    Nouso K, Kobayashi Y, Nakamura S, Kobayashi S, Takayama H, Toshimori J, Kuwaki K, Hagihara H, Onishi H, Miyake Y, Ikeda F, Shiraha H, Takaki A, Iwasaki Y, Kobashi H, Yamamoto K.
    J Gastroenterol Hepatol; 2011 Jul 22; 26(7):1195-200. PubMed ID: 21410750
    [Abstract] [Full Text] [Related]

  • 16. [Clinical usefulness of lectin-reactive fraction of alpha-fetoprotein in hepatocellular carcinoma].
    Tamura A, Oita T, Sakizono K, Nakajima T, Kasakura S.
    Rinsho Byori; 1998 Feb 22; 46(2):158-62. PubMed ID: 9528340
    [Abstract] [Full Text] [Related]

  • 17. Lens culinaris agglutinin-reactive α-fetoprotein decline after transcatheter arterial chemoembolization in patients with hepatocellular carcinoma predicts survival.
    Huang C, Sheng S, Sun X, Liu J, Huang G.
    Clin Chim Acta; 2014 Apr 20; 431():232-8. PubMed ID: 24565960
    [Abstract] [Full Text] [Related]

  • 18. The utility of Lens culinaris agglutinin-reactive alpha-fetoprotein in the diagnosis of hepatocellular carcinoma: evaluation in a United States referral population.
    Leerapun A, Suravarapu SV, Bida JP, Clark RJ, Sanders EL, Mettler TA, Stadheim LM, Aderca I, Moser CD, Nagorney DM, LaRusso NF, de Groen PC, Menon KV, Lazaridis KN, Gores GJ, Charlton MR, Roberts RO, Therneau TM, Katzmann JA, Roberts LR.
    Clin Gastroenterol Hepatol; 2007 Mar 20; 5(3):394-402; quiz 267. PubMed ID: 17368240
    [Abstract] [Full Text] [Related]

  • 19. Serum proteomics and biomarkers in hepatocellular carcinoma and chronic liver disease.
    Zinkin NT, Grall F, Bhaskar K, Otu HH, Spentzos D, Kalmowitz B, Wells M, Guerrero M, Asara JM, Libermann TA, Afdhal NH.
    Clin Cancer Res; 2008 Jan 15; 14(2):470-7. PubMed ID: 18223221
    [Abstract] [Full Text] [Related]

  • 20. Staging hepatocellular carcinoma by a novel scoring system (BALAD score) based on serum markers.
    Toyoda H, Kumada T, Osaki Y, Oka H, Urano F, Kudo M, Matsunaga T.
    Clin Gastroenterol Hepatol; 2006 Dec 15; 4(12):1528-36. PubMed ID: 17162244
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.